Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Wistar researchers discover new enzymatic function of the Epstein-Barr Virus protein

Wistar researchers discover new enzymatic function of the Epstein-Barr Virus protein

Two enzymes fuel transition from pre-cancer stem cells to leukemia stem cells

Two enzymes fuel transition from pre-cancer stem cells to leukemia stem cells

COVID-19, influenza and suicide are responsible for deaths of ICE detainees

COVID-19, influenza and suicide are responsible for deaths of ICE detainees

New drug target valid for breast cancer as well as lymphoma

New drug target valid for breast cancer as well as lymphoma

Eliminating key gene could revive exhausted immune cells to battle solid tumors

Eliminating key gene could revive exhausted immune cells to battle solid tumors

FISH technique can be used to probe sperm DNA for chromosomal defects

FISH technique can be used to probe sperm DNA for chromosomal defects

Prolonged shedding and multiple mutations 154 days after initial SARS-CoV-2 diagnosis reported

Prolonged shedding and multiple mutations 154 days after initial SARS-CoV-2 diagnosis reported

5 reasons to wear a mask even after you’re vaccinated

5 reasons to wear a mask even after you’re vaccinated

ADC histogram analysis can predict tumor proliferation, survival in immunocompetent patients with PCNSL

ADC histogram analysis can predict tumor proliferation, survival in immunocompetent patients with PCNSL

MDC researchers develop a potent weapon against lymphomas

MDC researchers develop a potent weapon against lymphomas

FDA conditionally approves first oral treatment for dogs with lymphoma

FDA conditionally approves first oral treatment for dogs with lymphoma

NCCN publishes new informational resources on health and wellness for cancer survivors

NCCN publishes new informational resources on health and wellness for cancer survivors

Seniors face crushing drug costs as Congress stalls on capping Medicare out-of-pockets

Seniors face crushing drug costs as Congress stalls on capping Medicare out-of-pockets

New cell therapy can boost immunotherapy against breast cancer

New cell therapy can boost immunotherapy against breast cancer

Cancer survivors have greater risk of developing and dying from subsequent primary cancers

Cancer survivors have greater risk of developing and dying from subsequent primary cancers

COVID-19 pandemic highlights the risk of using systemic corticosteroids

COVID-19 pandemic highlights the risk of using systemic corticosteroids

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

Scientists demonstrate a promising strategy for treating lymphomas

Scientists demonstrate a promising strategy for treating lymphomas

New class of targeted cancer drugs may prove effective in treating common types of leukemia

New class of targeted cancer drugs may prove effective in treating common types of leukemia

Study shows how STAT5 optimizes function of CD4+ T cells to drive antitumor immunity

Study shows how STAT5 optimizes function of CD4+ T cells to drive antitumor immunity